Raymond  Huggenberger net worth and biography

Raymond Huggenberger Biography and Net Worth

Director of Inogen
Raymond O. Huggenberger is Independent Director of Inogen, Inc. Mr. Huggenberger previously served as our Chief Executive Officer from 2008 until March 1, 2017 and as our President from 2008 until January 1, 2016. Prior to joining our company, Mr. Huggenberger held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, including: Vice President of Marketing for Sunrise’s German subsidiary from 1994 to 1996, President of Sunrise’s German division from 1998 until 2000, President of the European Operating Group from 2000 to 2002, President and Chief Operating Officer from 2002 until 2004, and President of European Operations 2006 to 2007. Mr. Huggenberger also held a consultant position with McDermott and Bull Inc., an executive search firm, from 2005 to 2006 and the position of Managing Director in the healthcare division of TA Triumph Adler AG, a document process management firm, from 1996 to 1998. Mr. Huggenberger currently serves on the Board of Directors of Tactile Systems Technology Inc., a publicly traded company, Clarify Medical Inc., Ebb Therapeutics, and Sommetrics, Inc., which are all medical device companies, as well as Intricon Corporation, a medical technology company. Mr. Huggenberger graduated from AKAD University in Rendsburg, Germany in Economics and completed the Advanced Marketing Strategies Program at INSEAD, Fontainebleau, France. The Board believes that he is qualified to serve as a director of Inogen because of his deep understanding of our business, operations and strategy and extensive executive and director roles with healthcare companies.

What is Raymond Huggenberger's net worth?

The estimated net worth of Raymond Huggenberger is at least $247,059.15 as of July 15th, 2021. Mr. Huggenberger owns 24,583 shares of Inogen stock worth more than $247,059 as of November 16th. This net worth estimate does not reflect any other investments that Mr. Huggenberger may own. Learn More about Raymond Huggenberger's net worth.

How do I contact Raymond Huggenberger?

The corporate mailing address for Mr. Huggenberger and other Inogen executives is 326 BOLLAY DRIVE, GOLETA CA, 93117. Inogen can also be reached via phone at (805) 562-0500 and via email at [email protected]. Learn More on Raymond Huggenberger's contact information.

Has Raymond Huggenberger been buying or selling shares of Inogen?

Raymond Huggenberger has not been actively trading shares of Inogen over the course of the past ninety days. Most recently, Raymond Huggenberger sold 6,594 shares of the business's stock in a transaction on Monday, August 16th. The shares were sold at an average price of $62.69, for a transaction totalling $413,377.86. Learn More on Raymond Huggenberger's trading history.

Who are Inogen's active insiders?

Inogen's insider roster includes Alison Bauerlein (CFO), Raymond Huggenberger (Director), Byron Myers (EVP), and Brenton Taylor (EVP). Learn More on Inogen's active insiders.

Are insiders buying or selling shares of Inogen?

In the last year, insiders at the medical technology company sold shares 1 times. They sold a total of 10,000 shares worth more than $85,600.00. The most recent insider tranaction occured on May, 10th when EVP Jason Somer sold 10,000 shares worth more than $85,600.00. Insiders at Inogen own 1.0% of the company. Learn More about insider trades at Inogen.

Information on this page was last updated on 5/10/2024.

Raymond Huggenberger Insider Trading History at Inogen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2021Sell6,594$62.69$413,377.86View SEC Filing Icon  
7/15/2021Sell7,000$65.83$460,810.0024,583View SEC Filing Icon  
6/15/2021Sell7,087$63.81$452,221.4727,670View SEC Filing Icon  
1/15/2019Sell8,500$136.81$1,162,885.0011,297View SEC Filing Icon  
12/14/2018Sell8,500$130.45$1,108,825.0011,297View SEC Filing Icon  
10/15/2018Sell10,500$196.62$2,064,510.008,797View SEC Filing Icon  
9/14/2018Sell10,500$282.57$2,966,985.008,797View SEC Filing Icon  
8/15/2018Sell10,500$228.63$2,400,615.00View SEC Filing Icon  
7/16/2018Sell10,593$194.51$2,060,444.438,890View SEC Filing Icon  
6/15/2018Sell10,444$183.50$1,916,474.008,741View SEC Filing Icon  
1/16/2018Sell13,000$116.19$1,510,470.0010,208View SEC Filing Icon  
12/15/2017Sell14,000$119.92$1,678,880.007,808View SEC Filing Icon  
10/16/2017Sell14,000$94.07$1,316,980.007,808View SEC Filing Icon  
9/15/2017Sell14,000$102.30$1,432,200.007,808View SEC Filing Icon  
8/15/2017Sell14,000$91.67$1,283,380.007,808View SEC Filing Icon  
7/14/2017Sell14,000$92.96$1,301,440.007,808View SEC Filing Icon  
6/15/2017Sell15,300$90.88$1,390,464.007,808View SEC Filing Icon  
1/17/2017Sell5,680$63.96$363,292.8012,488View SEC Filing Icon  
12/15/2016Sell8,000$65.59$524,720.0014,808View SEC Filing Icon  
10/17/2016Sell7,089$56.24$398,685.368,342View SEC Filing Icon  
8/15/2016Sell20,747$57.48$1,192,537.5627,555View SEC Filing Icon  
7/18/2016Sell20,747$50.41$1,045,856.2727,555View SEC Filing Icon  
6/16/2016Sell20,747$47.86$992,951.4227,555View SEC Filing Icon  
5/16/2016Sell20,746$44.18$916,558.2827,554View SEC Filing Icon  
4/15/2016Sell29,635$48.59$1,439,964.6525,210View SEC Filing Icon  
10/21/2015Sell57,418$43.06$2,472,419.086,808View SEC Filing Icon  
9/15/2015Sell57,416$53.58$3,076,349.286,808View SEC Filing Icon  
2/19/2015Sell25,722$33.95$873,261.90View SEC Filing Icon  
1/20/2015Sell25,722$31.63$813,586.86View SEC Filing Icon  
12/19/2014Sell25,722$28.98$745,423.56View SEC Filing Icon  
11/19/2014Sell25,722$24.25$623,758.50View SEC Filing Icon  
11/4/2014Sell165,891$20.21$3,352,657.11View SEC Filing Icon  
9/22/2014Sell25,722$20.25$520,870.50View SEC Filing Icon  
See Full Table

Raymond Huggenberger Buying and Selling Activity at Inogen

This chart shows Raymond Huggenberger's buying and selling at Inogen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inogen Company Overview

Inogen logo
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Read More

Today's Range

Now: $10.05
Low: $9.70
High: $10.08

50 Day Range

MA: $9.82
Low: $8.69
High: $11.56

2 Week Range

Now: $10.05
Low: $4.93
High: $13.33

Volume

171,150 shs

Average Volume

333,613 shs

Market Capitalization

$239.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04